# A Study of Brepocitinib in Adults With Active Non-Infectious Non-Anterior Uveitis

> **NCT05523765** · PHASE2 · COMPLETED · sponsor: **Priovant Therapeutics, Inc.** · enrollment: 26 (actual)

## Conditions studied

- Non-infectious Intermediate Uveitis
- Non-infectious Posterior Uveitis
- Non-infectious Pan Uveitis

## Interventions

- **DRUG:** Brepocitinib

## Key facts

- **NCT ID:** NCT05523765
- **Lead sponsor:** Priovant Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-11-14
- **Primary completion:** 2024-07-30
- **Final completion:** 2024-07-30
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2025-07-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05523765

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05523765, "A Study of Brepocitinib in Adults With Active Non-Infectious Non-Anterior Uveitis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05523765. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*